353 related articles for article (PubMed ID: 32561416)
1. Hypoxia in bone metastasis and osteolysis.
Todd VM; Johnson RW
Cancer Lett; 2020 Oct; 489():144-154. PubMed ID: 32561416
[TBL] [Abstract][Full Text] [Related]
2. Basic mechanisms responsible for osteolytic and osteoblastic bone metastases.
Guise TA; Mohammad KS; Clines G; Stebbins EG; Wong DH; Higgins LS; Vessella R; Corey E; Padalecki S; Suva L; Chirgwin JM
Clin Cancer Res; 2006 Oct; 12(20 Pt 2):6213s-6216s. PubMed ID: 17062703
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia inducible factor-1 is activated by transcriptional co-activator with PDZ-binding motif (TAZ) versus WWdomain-containing oxidoreductase (WWOX) in hypoxic microenvironment of bone metastasis from breast cancer.
Bendinelli P; Maroni P; Matteucci E; Luzzati A; Perrucchini G; Desiderio MA
Eur J Cancer; 2013 Jul; 49(11):2608-18. PubMed ID: 23566416
[TBL] [Abstract][Full Text] [Related]
4. Hypoxic Microenvironment and Metastatic Bone Disease.
Hiraga T
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30423905
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer.
Hiraga T; Kizaka-Kondoh S; Hirota K; Hiraoka M; Yoneda T
Cancer Res; 2007 May; 67(9):4157-63. PubMed ID: 17483326
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia induced E-cadherin involving regulators of Hippo pathway due to HIF-1α stabilization/nuclear translocation in bone metastasis from breast carcinoma.
Maroni P; Matteucci E; Drago L; Banfi G; Bendinelli P; Desiderio MA
Exp Cell Res; 2015 Jan; 330(2):287-299. PubMed ID: 25447306
[TBL] [Abstract][Full Text] [Related]
7. Role of Lysine-Specific Demethylase 1 in Metabolically Integrating Osteoclast Differentiation and Inflammatory Bone Resorption Through Hypoxia-Inducible Factor 1α and E2F1.
Doi K; Murata K; Ito S; Suzuki A; Terao C; Ishie S; Umemoto A; Murotani Y; Nishitani K; Yoshitomi H; Fujii T; Watanabe R; Hashimoto M; Murakami K; Tanaka M; Ito H; Park-Min KH; Ivashkiv LB; Morinobu A; Matsuda S
Arthritis Rheumatol; 2022 Jun; 74(6):948-960. PubMed ID: 35077015
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia and Bone Metastatic Disease.
Johnson RW; Sowder ME; Giaccia AJ
Curr Osteoporos Rep; 2017 Aug; 15(4):231-238. PubMed ID: 28597139
[TBL] [Abstract][Full Text] [Related]
9. Hypoxic pathobiology of breast cancer metastasis.
Schito L; Rey S
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):239-245. PubMed ID: 28526262
[TBL] [Abstract][Full Text] [Related]
10. Intermittent hypoxia effect on osteoclastogenesis stimulated by neuroblastoma cells.
Bhaskara VK; Mohanam I; Gujrati M; Mohanam S
PLoS One; 2014; 9(8):e105555. PubMed ID: 25148040
[TBL] [Abstract][Full Text] [Related]
11. Implications of Hypoxia in Breast Cancer Metastasis to Bone.
Gilkes DM
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27706047
[TBL] [Abstract][Full Text] [Related]
12. Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment.
Li Z; Xiao J; Wu X; Li W; Yang Z; Xie J; Xu L; Cai X; Lin Z; Guo W; Luo J; Liu M
Curr Mol Med; 2012 Sep; 12(8):967-81. PubMed ID: 22574935
[TBL] [Abstract][Full Text] [Related]
13. A mechanobiological model of bone metastasis reveals that mechanical stimulation inhibits the pro-osteolytic effects of breast cancer cells.
Kumar V; Naqvi SM; Verbruggen A; McEvoy E; McNamara LM
Cell Rep; 2024 May; 43(5):114043. PubMed ID: 38642336
[TBL] [Abstract][Full Text] [Related]
14. A cross-species analysis of a mouse model of breast cancer-specific osteolysis and human bone metastases using gene expression profiling.
Sadanandam A; Futakuchi M; Lyssiotis CA; Gibb WJ; Singh RK
BMC Cancer; 2011 Jul; 11():304. PubMed ID: 21774828
[TBL] [Abstract][Full Text] [Related]
15. Tumor-derived miR-378a-3p-containing extracellular vesicles promote osteolysis by activating the Dyrk1a/Nfatc1/Angptl2 axis for bone metastasis.
Wang J; Du X; Wang X; Xiao H; Jing N; Xue W; Dong B; Gao WQ; Fang YX
Cancer Lett; 2022 Feb; 526():76-90. PubMed ID: 34801597
[TBL] [Abstract][Full Text] [Related]
16. A hypoxic ticket to the bone metastatic niche.
Vanharanta S
Breast Cancer Res; 2015 Sep; 17(1):122. PubMed ID: 26337273
[TBL] [Abstract][Full Text] [Related]
17. Hypoxic control of metastasis.
Rankin EB; Giaccia AJ
Science; 2016 Apr; 352(6282):175-80. PubMed ID: 27124451
[TBL] [Abstract][Full Text] [Related]
18. HIF signaling in osteoblast-lineage cells promotes systemic breast cancer growth and metastasis in mice.
Devignes CS; Aslan Y; Brenot A; Devillers A; Schepers K; Fabre S; Chou J; Casbon AJ; Werb Z; Provot S
Proc Natl Acad Sci U S A; 2018 Jan; 115(5):E992-E1001. PubMed ID: 29339479
[TBL] [Abstract][Full Text] [Related]
19. Small extracellular vesicles deliver osteolytic effectors and mediate cancer-induced osteolysis in bone metastatic niche.
Ma Q; Liang M; Wu Y; Dou C; Xu J; Dong S; Luo F
J Extracell Vesicles; 2021 Feb; 10(4):e12068. PubMed ID: 33659051
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia inducible factor 1α-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer.
Ji F; Wang Y; Qiu L; Li S; Zhu J; Liang Z; Wan Y; Di W
Int J Oncol; 2013 May; 42(5):1578-88. PubMed ID: 23545606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
